BMRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The zones of discrimination for M-Score is as such:
An M-Score of less than -2.22 suggests that the company is not an accounting manipulator.
An M-Score of greater than -2.22 signals that the company is likely an accounting manipulator.
Biomarin Pharmaceutical Inc has a M-score of -3.00 suggests that the company is not a manipulator.
During the past 13 years, the highest Beneish M-Score of Biomarin Pharmaceutical Inc was 7.17. The lowest was -5.36. And the median was -2.11.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Z-Score) or business trend (F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Biomarin Pharmaceutical Inc for today is based on a combination of the following eight different indices:
|M||=||-4.84||+||0.92 * DSRI||+||0.528 * GMI||+||0.404 * AQI||+||0.892 * SGI||+||0.115 * DEPI|
|=||-4.84||+||0.92 * 0.7784||+||0.528 * 0.9758||+||0.404 * 0.936||+||0.892 * 1.2502||+||0.115 * 1.5657|
|-||0.172 * SGAI||+||4.679 * TATA||-||0.327 * LVGI|
|-||0.172 * 1.0047||+||4.679 * -0.0268||-||0.327 * 2.3312|
|This Year (Sep14) TTM:||Last Year (Sep13) TTM:|
|Accounts Receivable was $121.4 Mil.|
Revenue was 176.847 + 191.787 + 151.552 + 146.873 = $667.1 Mil.
Gross Profit was 146.927 + 160.577 + 128.736 + 122.252 = $558.5 Mil.
Total Current Assets was $1,077.8 Mil.
Total Assets was $2,440.4 Mil.
Property, Plant and Equipment(Net PPE) was $486.7 Mil.
Depreciation, Depletion and Amortization(DDA) was $49.7 Mil.
Selling, General & Admin. Expense(SGA) was $274.6 Mil.
Total Current Liabilities was $206.6 Mil.
Long-Term Debt was $656.9 Mil.
Net Income was 7.445 + -33.502 + -38.115 + -61.99 = $-126.2 Mil.
Non Operating Income was -0.299 + -1.36 + -0.491 + -0.613 = $-2.8 Mil.
Cash Flow from Operations was -8.356 + -11.532 + -26.874 + -11.296 = $-58.1 Mil.
|Accounts Receivable was $124.7 Mil.
Revenue was 136.874 + 136.81 + 127.928 + 131.938 = $533.6 Mil.
Gross Profit was 108.82 + 114.243 + 107.428 + 105.406 = $435.9 Mil.
Total Current Assets was $713.5 Mil.
Total Assets was $1,620.5 Mil.
Property, Plant and Equipment(Net PPE) was $285.7 Mil.
Depreciation, Depletion and Amortization(DDA) was $48.4 Mil.
Selling, General & Admin. Expense(SGA) was $218.6 Mil.
Total Current Liabilities was $167.6 Mil.
Long-Term Debt was $78.3 Mil.
1. DSRI = Days Sales in Receivables Index
A large increase in DSR could be indicative of revenue inflation.
|DSRI||=||(Receivables_t / Revenue_t)||/||(Receivables_t-1 / Revenue_t-1)|
|=||(121.395 / 667.059)||/||(124.745 / 533.55)|
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
|=||(GrossProfit_t-1 / Revenue_t-1)||/||(GrossProfit_t / Revenue_t)|
|=||(160.577 / 533.55)||/||(146.927 / 667.059)|
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
|AQI||=||(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)||/||(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)|
|=||(1 - (1077.819 + 486.741) / 2440.433)||/||(1 - (713.479 + 285.664) / 1620.53)|
4. SGI = Sales Growth Index
Ratio of sales in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
5. DEPI = Depreciation Index
Measured as the ratio of the rate of depreciation in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
|DEPI||=||(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))||/||(Depreciation_t / (Depreciaton_t + PPE_t))|
|=||(48.425 / (48.425 + 285.664))||/||(49.657 / (49.657 + 486.741))|
6. SGAI = Sales, General and Administrative expenses Index
The ratio of SGA expenses in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
|SGAI||=||(SGA_t / Sales_t)||/||(SGA_t-1 /Sales_t-1)|
|=||(274.571 / 667.059)||/||(218.596 / 533.55)|
7. LVGI = Leverage Index
The ratio of total debt to total assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase$sgai= in leverage
|LVGI||=||((LTD_t + CurrentLiabilities_t) / TotalAssets_t)||/||((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)|
|=||((656.884 + 206.55) / 2440.433)||/||((78.31 + 167.633) / 1620.53)|
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
|=||(NetIncome_t - NonOperatingIncome_t||-||CashFlowsfromOperations_t)||/||TotalAssets_t|
|=||(-126.162 - -2.763||-||-58.058)||/||2440.433|
An M-Score of less than -2.22 suggests that the company will not be a manipulator. An M-Score of greater than -2.22 signals that the company is likely to be a manipulator.
Biomarin Pharmaceutical Inc has a M-score of -3.00 suggests that the company will not be a manipulator.
Altman Z-Score, Piotroski F-Score, Accounts Receivable, Revenue, Gross Profit, Total Current Assets, Total Assets, Property, Plant and Equipment, Depreciation, Depletion and Amortization, Selling, General & Admin. Expense, Total Current Liabilities, Long-Term Debt, Net Income, Non Operating Income, Cash Flow from Operations
Biomarin Pharmaceutical Inc Annual Data
Biomarin Pharmaceutical Inc Quarterly Data